Dermatologic Reactions to Immune Checkpoint Inhibitors

Article Properties

Language

English
DOI (url)

10.1007/s40257-017-0336-3
Publication Date

2017/12/18
Journal

American Journal of Clinical Dermatology
Indian UGC (Journal)
Refrences

108
Citations

375
Vincent Sibaud ORCID (unauthenticated)

Cite

Sibaud, Vincent. “Dermatologic Reactions to Immune Checkpoint Inhibitors”. American Journal of Clinical Dermatology, vol. 19, no. 3, 2017, pp. 345-61, https://doi.org/10.1007/s40257-017-0336-3.

Sibaud, V. (2017). Dermatologic Reactions to Immune Checkpoint Inhibitors. American Journal of Clinical Dermatology, 19(3), 345-361. https://doi.org/10.1007/s40257-017-0336-3

Sibaud V. Dermatologic Reactions to Immune Checkpoint Inhibitors. American Journal of Clinical Dermatology. 2017;19(3):345-61.

Journal Categories

Medicine

Dermatology

Medicine

Medicine (General)

Refrences

Refrences Analysis

Category	Category Repetition
Medicine: Medicine (General)	69
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens	32
Medicine: Dermatology	26
Medicine	15
Medicine: Internal medicine	9

The category Medicine: Medicine (General) 69 is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine The chart below illustrates the number of referenced publications per year.

Refrences used by this article by year

Citations

Citations Analysis

Category	Category Repetition
Medicine: Medicine (General)	227
Medicine: Dermatology	102
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens	98
Medicine	46
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy	43

The first research to cite this article was titled Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma and was published in 2018. The most recent citation comes from a 2024 study titled Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma . This article reached its peak citation in 2021 , with 81 citations.It has been cited in 199 different journals, 22% of which are open access. Among related journals, the Frontiers in Immunology cited this research the most, with 17 citations. The chart below illustrates the annual citation trends for this article.